Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: A UK perspective

Regulatory Toxicology and Pharmacology

Volumn 40, Issue 1, 2004, Pages 54-66

  Pufulete, M ^a   Battershill, J ^b   Boobis, A ^c   Fielder, R ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b S ^*  (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Carcinogenicity; DNA adducts; Polycyclic aromatic hydrocarbons; Potency equivalency factors; Risk assessment

Indexed keywords

POLYCYCLIC AROMATIC HYDROCARBON;

AIR POLLUTION; AIR QUALITY; BIOASSAY; CARCINOGENIC ACTIVITY; CORRELATION ANALYSIS; DNA ADDUCT; DOSE RESPONSE; EXPOSURE; KINETICS; LUNG TUMOR; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED KINGDOM;

RODENTIA;

EID: 3242700379     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2004.04.007     Document Type: Article

References (66)

1. Armstrong B., Tremblay C., Baris D., Theriault G. Lung cancer mortality and polynuclear aromatic hydrocarbons: a case-cohort study of aluminium production workers in Arvida, Quebec, Canada. Am. J. Epidemiol. 139:1994;250-262
2. Baer-Dubowska W. Alternative pathways of polycyclic aromatic hydrocarbons activation: the formation of polar DNA adducts. Acta Biochim. Pol. 46:1999;263-274
3. Baulig A., Garlatti M., Bonvallot V., Marchand A., Barouki R., Marano F., Baeza-Squiban A. Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285:2003;671-679
4. Bond J.A. Some biotransformation enzymes responsible for polycyclic aromatic hydrocarbon metabolism in rat nasal turbinates: effects on enzyme activities of in vitro modifiers and intraperitoneal and inhalation exposure of rats to inducing agents. Cancer Res. 43:1983;4805-4811
5. Bond J.A., Baker S.M., Bechtold W.E. Correlation of the octanol/water partition coefficient with clearance half-times of intratracheally instilled aromatic hydrocarbons in rats. Toxicology. 36:1985;285-295
6. Boobis A.R., Nebert D.W., Felton J.S. Comparison of beta-naphthoflavone and 3-methylcholanthrene as inducers of hepatic cytochrome(s) P-448 and aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity. Mol. Pharmacol. 13:1977;259-268
7. Brooks R.A., Gooderham N.J., Edwards R.J., Boobis A.R., Winton D.J. The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis. 20:1999;109-114
8. Brown, R., Mittelman, A., 1993. Evaluation of existing methods to rank the relative carcinogenicity of polycyclic aromatic compounds (PAH). Technical Resources, Inc. Draft for Office of Emergency and Remedial Response, Office of Solid Waste and Emergency Response, US Environmental Protection Agency. Contract No. 68-01-0022
9. Cavalieri E.L., Rogan E.G., Higginbotham S., Cremonesi P., Salmasi S. Tumour-initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]pyrene. J. Cancer Res. Clin. Oncol. 115:1989;67-72
10. Cavalieri E.L., Higginbotham S., RamaKrishna N.V., Devanesan P.D., Todorovic R., Rogan E.G., Salmasi S. Comparative dose-response tumourigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis. 12:1991;1939-1944
11. Chu, M.M.L., Chen, C.W., 1984. Evaluation and estimation of potential carcinogenic risks of polynuclear aromatic hydrocarbons. Symposium on Polycyclic Aromatic Hydrocarbons in the Workplace. Honolulu, HI. Pacific Rim Risk Conference
12. Clement Associates, 1988. Comparative potency approach for estimating the cancer risk associated with exposure to mixtures of polycyclic aromatic hydrocarbons. Fairfax, Virginia, ICF-Clement Associates, Interim final report, 68-02-4403
13. Coleman, P., Bush, T., Connoly, C., Irons, S., Murrells, T., Vincent, K, Watterson, J., 2001. Assessment of benzo[a]pyrene atmospheric concentrations in the UK to support the establishment of a national PAH objectve. Department of the Environment, Transport and the Regions, the National Assembly for Wales, the Scottish Executive and the Department of the Environment for Northern Ireland. AEAT/ENV/R/0620. AEA Technology
14. Collins J.F., Brown J.P., Alexeeff G.V., Salmon A.G. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Phramacol. 28:1998;45-54
15. Conney A.H., Miller E.C., Miller J.A. The metabolism of methylated aminoazo dyes. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 16:1956;450-459
16. De Raat W.K., de Meijere F.A., Kooijman S.A. Mutagenicity of ambient aerosol collected in an urban and industrial area of The Netherlands. Sci. Total Environ. 44:1985;17-33
17. De Raat W.K., Kooijman S.A., Gielen J.W. Concentrations of polycyclic hydrocarbons in airborne particles in The Netherlands and their correlation with mutagenicity. Sci. Total Environ. 66:1987;95-114
18. De Vries A., van Oostrom C.Th.M., Dortant P.M, Beems R.B., van Kreijl C.F., Capel P.J., van Steeg H. Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinog. 19:1997;46-53
19. Department of the Environment, Transport and the Regions National Assembly for Wales Scottish Executive and the Department of the Environment Northern Ireland, 1999. Expert Panel on Air Quality Standards. Polycyclic Aromatic Hydrocarbons. London: The Stationery Office
20. Deutsch-Wenzel R.P., Brune H., Grimmer G., Dettbarn G., Misfeld J. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 71:1983;539-544
21. Farant J.-P., Gariépy M. Relationship between benzo[a]pyrene and individual polycyclic aromatic hydrocarbons in a Söderberg primary aluminium smelter. Am. Ind. Hygiene Assoc. J. 59:1998;758-765
22. Foureman, G.L., and Smith, R.L., 1999. A proposed procedure for derivation of regulatory values for carcinogenic airborne polycyclic aromatic hydrocarbons (PAHs) based on coal tar pitch (CTP) volatiles. Air Waste Management Association Proceedings, paper 99-259. Air & Waste Management Association 92nd Annual Meeting & Exhibition, June 20-24, St. Louis, Missouri
23. Gerde P., Muggenburg B.A., Lundborg M., Tesfaigzi Y., Dahl A.R. Respiratory epithelial penetration and clearance of particle-borne benzo[a]pyrene. Res. Rep. Health Eff. Inst. 101:2001;5-25
24. Goldstein L.S., Weyand E.H., Safe S., Steinberg M., Culp S.J., Gaylor D.W., Beland F.A., Rodriguez L.V. Tumours and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment. Environ. Health Perspect. 106(Suppl. 6):1998;1325-1330
25. Habs M., Schmahl D., Misfeld J. Local carcinogenicity of some environmentally relevant polycyclic aromatic hydrocarbons after lifelong topical application to mouse skin. Arch. Gerschwulstforsch. 50:1980;266-274
26. Hakura A., Tsutsui Y., Sonoda J., Tsukidate K., Mikami T., Sagami F. Comparison of mutational spectras of the lacZ transgene in four organs of the Mut Mouse treated with benzo(a)pyrene. Mut. Res. 447:2000;239-247
27. Hakura A., Tsutsui Y., Sonoda J., Kai J., Imade T., Shimada M., Sugihara Y., Mikami T. Compariosn between in-vivo mutagenicity and carcinogenicity in multiple organs by benzo(a)pyrene in the lacZ transgenic mouse. Mut. Res. 398:1998;123-130
28. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340
29. Hietanen E., Laitinen M., Koivusaari U. Effect of administration route of 3-methylcholanthrene on the inducibility of intestinal drug-metabolizing enzymes. Enzyme. 25:1980;153-157
30. Higginbotham S., RamaKrishna M.V., Johansson S.L., Rogan E.G., Cavalieri E.L. Tumour initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis. 14:1993;875-878
31. Hughes N.C., Phillips D.H. Covalent binding of dinbenzpyrene and benzo(a)pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcinogenesis. 11:1990;1611-1619
32. IARC, 2004. List of IARC evaluations. International Agency for Research on Cancer, Lyon, France. Available from 〈http://monographs.iarc.fr/ monoeval/grlist.html〉
33. Krewski D., Thorslund T., Withey J. Carcinogenic risk assessment of complex mixtures. Toxicol. Ind. Health. 5:1989;851-867
34. Luch A., Friesel H., Seidel A., Platt K.L. Tumour-initiating activity of the (+)-(S,S)- and (-)-(R,R)-enantiomers of trans-11,12-dihydroxy-11,12- dihydrodibenzo[a,l]pyrene in mouse skin. Cancer Lett. 136:1999;119-128
35. Lioy, P.J., et al., 1987. In: Lioy, Daisy (Eds.), Toxic Air Pollution. Lewis Pub. Inc., Chelsea, MI, pp. 3-42
36. Malcolm, H.M., Dobson, S., 1994. The calculation of an Environmental Assessment Level (EAL) for atmospheric PHAs using relative potencies. London, Department of the Environment, pp 1-34, DoE/HMIP/RR/94/041
37. Mass M.J., Kaufman D.G. A comparison between the activation of benzo[a]pyrene in organ cultures and microsomes from the tracheal epithelium of rats and hamsters. Carcinogenesis. 4:1983;297-303
38. Mass M.J., Jeffers A.J., Ross J.A., Nelson G., Galati A.J., Stoner G.D., Nesnow S. Ki-ras oncogene mutations in tumours and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinog. 8:1993;186-192
39. McClure, P., Schoeny, R., 1995. Evaluation of a component-based relative potency approach to cancer risk assessment for exposure to PAH. In: Fifteenth International Symposium on Polycyclic Aromatic Compounds: Chemistry, Biology and Environmental Impact. Belgirate, Italy, 19-22 September, Ispra, Joint Research Centre European Commission
40. Moore C.J., Pruess-Schwartz D., Mauthe R.J., Gould M.N., Baird W.M. Interspecies differences in the major DNA adducts formed from benzo(a)pyrene but not 7,12-dimethylbenz(a)anthracene in rat and human mammary cell cultures. Cancer Res. 47:1987;4402-4406
41. Muller P., Leece B., Raha D. Scientific criteria document for multimedia standards development: polycyclic aromatic hydrocarbons (PAH). Part 1: Hazard identification and dose-response assessment. 1997;Standards Development Branch, Ontario Ministry of Environment and Energy, Ontario, Canada
42. Nesnow S., Triplett L.L., Slaga T.J. Comparative tumour-initiating activity of complex mixtures from environmental particulate emissions on SENCAR mouse skin. J. Natl. Cancer Inst. 68:1982;829-834
43. Nesnow S., Ross J.A., Stoner G.D., Mass M.J. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumourigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology. 105:1995;403-413
44. Nesnow S., Ross J.A., Mass M.J., Stoner G.D. Mechanistic relationships between DNA adducts, oncogene mutations and lung tumourigenesis in strain A mice. Exp. Lung Res. 24:1998;395-405
45. Nesnow S., Mass M.J., Ross J.A., Galatai A.J., Lambert G.R., Gennings C., Carter W.H. Jr., Stoner G.D. Lung tumourigenic interactions in strain A/J mice of five environmental polycyclic aromatic hydrocarbons. Environ. Health Perspect. 106(suppl 6):1998;1337-1346
46. Nikula K.J. Rat lung tumours induced by exposure to selected poorly soluble nonfibrous particles. Inhal. Toxicol. 12:2000;97-119
47. Nisbet I.C., LaGoy P.K. Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul. Toxicol. Pharmacol. 16:1992;290-300
48. Poirier M.C., Beland F.A. DNA adduct measurement and tumour incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem. Res. Toxicol. 5:1992;749-755
49. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S., Mass M.J. Dibenzo[a,l]pyrene-induced DNA adduction, tumourigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis. 18:1997;1955-1963
50. Roberts R.A., Crump K.S., Lutz W.K., Wiegand H.J., Williams G.M., Harrison P.T., Purchase I.F. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation. Arch. Toxicol. 75:2001;507-512
51. Ross J.A., Nelson G.B., Wilson K.H., Rabinowitz J.R., Galati A., Stoner G.D., Nesnow S., Mass J. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time integrated DNA adduct levels. Cancer Res. 55:1995;1039-1044
52. Saito Y., Azuma A., Kudo S., Takizawa H., Sugawara I. Long-term inhalation of diesel exhaust affects cytokine expression in murine lung tissues: comparison between low- and high-dose diesel exhaust exposure. Exp. Lung Res. 28:2002;493-506
53. Schlede E., Kuntzman R., Haber S., Conney A.H. Effect of enzyme induction on the metabolism and tissue distribution of benzo(alpha)pyrene. Cancer Res. 30:1970;2893-2897
54. Schneider K., Roller M., Kalberlah F., Schumacher-Wolz U. Cancer risk assessment for oral exposure to PAH mixtures. J. Appl. Toxicol. 22:2002;73-81
55. Seo K.Y., Jelinsky S.A., Loechler E.L. Factors that influence the mutagenic pattersn of DNA adducts from chemical carcinogens. Mut. Res. 463:2000;215-246
56. Slaga T.J., Fischer S.M., Weeks C.E., Klein-Szanto A.J., Reiners J. Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J. Cell Biochem. 18:2002;99-119
57. +/- hemizygous knockout mouse: overview of available data. Toxicol. Pathol. 29(suppl):2001;30-50
58. Sun J.D., Wolff R.K., Kanapilly G.M. Deposition, retention, and biological fate of inhaled benzo(a)pyrene adsorbed onto ultrafine particles and as a pure aerosol. Toxicol. Appl. Pharmacol. 65:1982;231-244
59. Sun J.D., Wolff R.K., Kanapilly G.M., McClellan R.O. Lung retention and metabolic fate of inhaled benzo(a)pyrene associated with diesel exhaust particles. Toxicol. Appl. Pharmacol. 73:1984;48-59
60. Talaska G., Jaeger M., Reilman R., Collins T., Warshawsky D. Chronic, topical exposure to benzo[a]pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc. Natl. Acad. Sci. USA. 93:1996;7789-7793
61. US EPA, Environmental Protection Agency, 1993. Provisional guidance for quantitative risk assessment of polycyclic aromatic hydrocarbons. Cincinnati, Ohio, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, EPA/600/R-93/089
62. US EPA, Environmental Protection Agency, 2002. Peer consultation workshop on approaches to polycyclic aromatic hydrocarbon (PAH) health assessment. National Center for Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Washington DC, EPA/635/R-02/005, January 2002
63. Van Oostrom C.T., Boeve M., van Den Berg J., de Vries A., Dolle M.E., Beems R.B., van Kreijl C.F., Vijg J., van Steeg H. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumours in DNA repair-deficient XPA mice. Environ. Mol. Mutagen. 34:1999;124-130
64. Wenzel-Hartung R., Brune H., Grimmer G., Germann P., Timm J., Wosniok W. Evaluation of the carcinogenic potency of 4 environmental polycyclic aromatic compounds following intrapulmonary application in rats. Exp. Pathol. 40:1990;221-227
65. Wild C.P., Pisani P. Carinogen-DNA and carcinogen-protein adducts in molecular epidemiology. Toniolo P., Boffett P., Shuker D.E.G., Rothman N., Hulka B., Pearce N. Application of Biomarkers in Cancer Epidemiology. 1997;IARC Scientific Publications, No 142. International Agency for Research on Cancer, Lyon
66. WHO, World Health Organisation, 1998. Environmental Health Criteria 202: Selected non-heterocyclic polycyclic aromatic hydrocarbons. IPCS, International Programme on Chemical Safety. World Health Organisation, Geneva